Article

Allergan introduces new drop for dry eye

Allergan Inc. has introduced an over-the-counter artificial tear (Optive Sensitive Preservative-Free Lubricant Eye Drops) for patients who have dry eye or dryness following LASIK.

Key Points

Irvine, CA-Allergan Inc. has introduced an over-the-counter artificial tear (Optive Sensitive Preservative-Free Lubricant Eye Drops) for patients who have dry eye or dryness following LASIK.

The drop is part of a line of artificial tears with a dual-action formula designed to provide a lubricating, hydrating, protective shield on the surface of the eye and also penetrate below the surface to provide corneal epithelial cells osmoprotection from excessive salt levels.

In a 30-day, randomized, controlled trial of 316 patients with dry eye, 157 patients who received the new artificial tear saw a statistically significant improvement in six common signs and symptoms of dry eye when compared with another drop (Refresh Plus, Allergan), according to the company. In a separate 90-day, randomized, controlled trial of 228 patients who had undergone LASIK, those who used the new drop experienced less ocular surface staining at 2 weeks after surgery when compared with patients who had used the other aforementioned artificial tear, according to the company. This trial also demonstrated a statistically significant improvement from baseline in patients' evaluation of dry eye symptoms, Allergan officials reported.

The new formulation is available in unit-dose vials.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.